The Max Foundation to make Novartis's Scemblix available in low- & middle-income countries

Retrieved on: 2022-12-16 18:50:14

Tags for this article:

Pharmaceutical companies

Leukemia

Computer access control

Computer network security

Virtual private network

Click the tags to see associated articles and topics

The Max Foundation to make Novartis's Scemblix available in low- & middle-income countries. View article details on HISWAI: https://cancerletter.com/in-brief/20221216_5d/

Excerpt

... and supportive services to patients globally, will launch access to ... to improve the overall patient-centered quality of care and navigation ...

Article found on: cancerletter.com

View Original Article